SAB Biotherapeutics (SABS) to Release Earnings on Monday
SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) is expected to be releasing its Q1 2025 earnings data before the market opens on Monday, May 19th. Analysts expect SAB Biotherapeutics to post earnings of ($1.00) per share and revenue of $0.13 million for the quarter. SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) last released its earnings […]
SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) is expected to be releasing its Q1 2025 earnings data before the market opens on Monday, May 19th. Analysts expect SAB Biotherapeutics to post earnings of ($1.00) per share and revenue of $0.13 million for the quarter. SAB Biotherapeutics (NASDAQ:SABS – Get Free Report) last released its earnings […]
-corp-logo-1200x675.jpg?v=20231005103726&w=240&h=240&zc=2){kind=logo}
